Article

Global Absence and Targeting of Protective Immune States in Severe COVID-19

2020-10-29

Abstract excerpt

While SARS-CoV-2 infection has pleiotropic and systemic effects in some patients, many others experience milder symptoms. We sought a holistic understanding of the severe/mild distinction in COVID-19 pathology, and its origins. We performed a whole-blood preserving single-cell analysis protocol to integrate contributions from all major cell types including neutrophils, monocytes, platelets, lymphocytes and the con...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2dc64f00-7049-56f0-ad4e-307937481bd5
DOI: 10.1101/2020.10.28.359935

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Global Absence and Targeting of Protective Immune States in Severe COVID-19DOI 10.1101/2020.10.28.359935Read

Global Absence and Targeting of Protective Immune States in Severe COVID-19.Semantic proximity Read

Single-cell multi-omics analysis of the immune response in COVID-19Semantic proximity Read

Suppressive myeloid cells are a hallmark of severe COVID-19Semantic proximity Read

Large-scale single-cell analysis reveals critical immune characteristics of COVID-19 patientsSemantic proximity Read

A single-cell atlas of the peripheral immune response to severe COVID-19Semantic proximity Read

Immune Response in Severe and Non-Severe Coronavirus Disease 2019 (COVID-19) Infection: A Mechanistic LandscapeSemantic proximity Read

The cellular immune response to COVID-19 deciphered by single cell multi-omics across three UK centresSemantic proximity Read

Characterisation of the blood RNA host response underpinning severity in COVID-19 patientsSemantic proximity Read

Immune Cell Profiling of COVID-19 Patients in the Recovery Stage by Single-Cell SequencingSemantic proximity Read

Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19Semantic proximity Read

Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcomeSemantic proximity Read

Early Fc-effector antibody signatures impact COVID-19 disease trajectorySemantic proximity Read